.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Federal Trade Commission
Queensland Health
Fuji
AstraZeneca
Johnson and Johnson
Moodys
Express Scripts
Harvard Business School

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089771

« Back to Dashboard
NDA 089771 describes MINITRAN, which is a drug marketed by Valeant Pharms, Valeant Pharms North, and Medicis, and is included in four NDAs. It is available from four suppliers. Additional details are available on the MINITRAN profile page.

The generic ingredient in MINITRAN is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

Summary for 089771

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 089771

Ingredient-typeNitrates
Physiological EffectVasodilation

Medical Subject Heading (MeSH) Categories for 089771

Suppliers and Packaging for NDA: 089771

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MINITRAN
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL 089771 ANDA Graceway Pharmaceuticals, LLC 29336-301 29336-301-02 30 PATCH in 1 CARTON (29336-301-02) > 1 d in 1 PATCH
MINITRAN
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL 089771 ANDA Graceway Pharmaceuticals, LLC 29336-321 29336-321-30 30 PATCH in 1 CARTON (29336-321-30) > 1 d in 1 PATCH

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.1MG/HR
Approval Date:Aug 30, 1996TE:AB1RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Queensland Health
Fuji
QuintilesIMS
UBS
McKesson
Fish and Richardson
Healthtrust
Teva
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot